Lv41
632 积分 2024-11-04 加入
U.S. FDA Approved Drugs from 2015–June 2020: A Perspective
19天前
已完结
Discovery of a Novel Ketohexokinase Inhibitor with Improved Drug Distribution in Target Tissue for the Treatment of Fructose Metabolic Disease
1个月前
已完结
Development of a novel PI3Kα/CDK7 potent hybrid inhibitor for Cancer treatment
1个月前
已完结
Bioorganic & Medicinal Chemistry Letters
1个月前
已完结
Discovery of BBI-355, a Potent, Selective, and Orally Available Checkpoint Kinase 1 Inhibitor for the Treatment of Extrachromosomal DNA Oncogene-Amplified Cancers
1个月前
已关闭
Siegfried H. Reich et al. Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition
1个月前
已完结
he Antinociceptive Agent SBFI-26 Binds to Anandamide Transporters FABP5 and FABP7 at Two Different Sites
2个月前
已完结
Use of Human Dose Prediction Metrics to Enable Discovery of AZD3470, an MTA-Cooperative PRMT5 Inhibitor in Clinical Evaluatio
3个月前
已完结
NMR Structure of a Potent Small Molecule Inhibitor Bound to Human Keratinocyte Fatty Acid-Binding Protein
3个月前
已完结
皖公网安备34019202002308
